LYINR 📈 Lyxor MSCI India UCITS Acc - Overview

Exchange: SW • Country: Switzerland • Currency: USD • Type: Etf • ISIN: FR0010375766 • India Equity

LYINR: Indian, Stocks, Equities

‣ Company URL: http://www.amundietf.com ‣ Domicile: France ‣ Index Name: Morningstar India TME NR USD

Additional Sources for LYINR ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

LYINR ETF Overview

Market Cap in USD 353m
Category India Equity
TER 0.85%
IPO / Inception 2006-11-07

LYINR ETF Ratings

Growth 5y 68.8%
Fundamental -
Dividend -
Rel. Strength Industry 261
Analysts -
Fair Price Momentum 30.07 USD
Fair Price DCF -

LYINR Dividends

No Dividends Paid

LYINR Growth Ratios

Growth Correlation 3m -64.3%
Growth Correlation 12m 75.4%
Growth Correlation 5y 84.1%
CAGR 5y 11.56%
CAGR/Mean DD 5y 1.41
Sharpe Ratio 12m 0.45
Alpha -6.58
Beta 0.56
Volatility 16.47%
Current Volume 0.8k
Average Volume 20d 17k
What is the price of LYINR stocks?
As of December 27, 2024, the stock is trading at USD 32.42 with a total of 833 shares traded.
Over the past week, the price has changed by -1.59%, over one month by -2.19%, over three months by -12.33% and over the past year by +10.90%.
Is Lyxor MSCI India UCITS Acc a good stock to buy?
Yes. Based on ValueRay Analyses, Lyxor MSCI India UCITS Acc (SW:LYINR) is currently (December 2024) a good stock to buy. It has a ValueRay Growth Rating of 68.84 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LYINR as of December 2024 is 30.07. This means that LYINR is currently overvalued and has a potential downside of -7.25%.
Is LYINR a buy, sell or hold?
Lyxor MSCI India UCITS Acc has no consensus analysts rating.
What are the forecast for LYINR stock price target?
According to ValueRays Forecast Model, LYINR Lyxor MSCI India UCITS Acc will be worth about 33 in December 2025. The stock is currently trading at 32.42. This means that the stock has a potential upside of +1.7%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 33 1.7%